Oct 04 2011 |
more articles from
|
INTERVIEW: Hikma Plans Fresh M&A Buys In MENA, Turkey Next Year
Tuesday, Oct 04, 2011
By Sten Stovall
Of DOW JONES NEWSWIRES
LONDON (Dow Jones)--Jordan-based Hikma Pharmaceuticals PLC (HIK.LN) says its acquisition of Morocco's ninth-largest pharmaceutical company provides "a missing link" to its home markets in the Middle East and North Africa and enables the expanding drug maker to focus on Turkey and the sub-Sahara to gain further scale.
Hikma late Monday said it bought 63.9% Morocco's Promopharm for $111.2 million and will launch a mandatory tender offer for the remainder.
Until now, Hikma wasn't in the Moroccan prescription drug market--the region's fourth-biggest in size--as local regulations require a manufacturing base. Morocco's market for pharmaceutical products was $1.7 billion last year. Promopharm had around 3.5% market share there, with annual sales of $45 million.
Promopharm 's original management team will stay to help Hikma build its business in Morocco. "The chairman and CEO will remain in place. They are very well connected and respected there and have run the company for over 15 years now," Darwazah said.
"We will make some other small acquisitions in the New Year, and also put emphasis on acquiring something in Turkey, which is becoming a more dominant player in MENA," Darwazah said in an interview. Hikma is also looking to strengthen its position in Egypt and Sudan via acquisitions.
The MENA region currently generates around 60% of total revenue for the company that Darwazah's father founded in 1978 and which is now one of the region's biggest domestic pharmaceuticals companies.
But the London-listed company, which sells generic and branded drugs, is expanding its businesses in the U.S. and Europe. In May, the company acquired U.S. firm Baxter International Inc.'s (BAX) injectable generic-drug business, reflecting Darwazah's aim of reducing risk through geographic diversification.
That strategy which should bring the percentage of Hikma 's sales generated in the MENA region down to 50% in around three years, Darwazah said.
-By Sten Stovall, Dow Jones Newswires; +44 207 842 9292; sten.stovall@dowjones.com
(END) Dow Jones Newswires
04-10-11 1404GMT
Zawya Comment Policy
-
Zawya encourages you to add a comment to this discussion. You agree that when you add content to this discussion your comments will not:
1.1 Contain any material which is libelous or defamatory of any person, is obscene, offensive, hateful or inflammatory or causes damage to the reputation of any person or organisation.
1.2 Promote sexually explicit material, violence, discrimination based on race, sex, religion, nationality, disability, sexual orientation or age or any illegal activity.
1.3 Be made in breach of any legal duty owed to a third party, such as a contractual duty or a duty of confidence.
1.4 Be threatening, abuse or invade another's privacy, or cause annoyance, inconvenience or needless anxiety.
1.5 Be used to impersonate any person, to misrepresent your identity or affiliation with any person, or be likely to deceive any person.
1.6 Give the impression that they represent Zawya.
1.7 Advocate, promote or assist any unlawful act such as (by way of example only) copyright infringement or computer misuse. - The content posted on www.zawya.com is created by members of the public. The views expressed are theirs and unless specifically stated are not those of Zawya. Zawya reserves the right to review all comments prior to posting and edit or delete any contribution, but Zawya is not responsible for and can not be held liable for any content posted by members of the public on www.zawya.com.
- Zawya is not responsible for the availability or content of any third party sites that are accessible through www.zawya.com. Any links to third party websites from www.zawya.com do not amount to any endorsement of that site by Zawya and any use of that site by you is at your own risk.
- By submitting your comment, you hereby give Zawya the right, but not the obligation, to post, air, edit, exhibit, telecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comments worldwide, in perpetuity.
Copyright © 2012 Zawya Ltd. All rights reserved. |
provided by www.zawya.com |
Post Your Comment